12:00 AM
 | 
Oct 22, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Adipose-derived stem and regenerative cells: Phase I/II started

Cytori began the double-blind, placebo-controlled, U.S. Phase I/II ATHENA trial evaluating ADRCs processed by the company's Celution One system in 45 patients with refractory heart failure due to chronic myocardial ischemia....

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >